World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   16532 records for 3322 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusProspective RegistrationMain ID Public TitleDate of RegistrationResults available
Not AvailableYesEUCTR2017-000617-23-NL
Research study to determine whether an investigational drug, SHP647, is safe and effective in the treatment of moderate to severe Crohn’s Disease, compared with placebo (dummy treatment) – using a randomised and blinded study design (investigator and patients are not aware whether they receive study drug or placebo.
17/04/2018 
AuthorisedYesEUCTR2016-004046-28-HR
A clinical study to assess the long-term safety and efficacy of Orelvo (voclosporin) compared with placebo in subjects with active lupus nephritis (LN)
13/04/2018 
AuthorisedYesEUCTR2017-002225-38-HR
A clinical study investigating the safety and tolerability of brexpiprazole in the Treatment of Subjects with Bipolar I Disorder
12/04/2018 
Not recruitingYesNCT03502694
Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Oral Lumicitabine Regimens in Hospitalized Adult Participants Infected With Human Metapneumovirus
11/04/2018 
AuthorisedYesEUCTR2016-004019-11-IT
A randomised, double-blind, parallel group, equivalence, multicentre phase III trial to compare the efficacy, safety and pharmakokinetics of HD201 to Herceptin® in patients with HER2+ early breast cancer 09/04/2018 
RecruitingYesNCT03498521
A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site 05/04/2018 
AuthorisedYesEUCTR2017-005140-16-GR
Phase IIa study of APL-2 in patients with PNH
02/04/2018 
Not AvailableYesEUCTR2017-001489-53-DE
Study of Ustekinumab in Subjects with Active Systemic Lupus Erythematosus
Recruitment statusMain IDPublic titleDate of registrationResults available
RecruitingNCT03517722 A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus 13/04/2018 
23/03/2018 
Not recruitingYesNCT03486080
Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial Infarction
12/03/2018 
RecruitingYesNCT03464136
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
07/03/2018 
      
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history